These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 7273443

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Serum 17 alpha-hydroxyprogesterone, 21-deoxycortisol and cortisol levels in congenital adrenal gland hyperplasia].
    Saito N, Niwa T, Nakauchi M, Nonoda A, Yoshida H.
    Horumon To Rinsho; 1977 Sep; 25(9):981-8. PubMed ID: 923123
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Diagnosis of congenital adrenal hyperplasia based on plasma 21-deoxycortisol level determined with a specific radioimmunoassay.
    Milewicz A, Vecsei P, Gruszka S, Szymczak J, Bednarek-Tupikowska G, Grabiński M.
    Mater Med Pol; 1984 Sep; 16(2-4):95-8. PubMed ID: 6335996
    [No Abstract] [Full Text] [Related]

  • 6. Rapid diagnosis of congenital adrenal hyperplasia by high performance liquid chromatography.
    Weisman Y, Bar A, Root A, Spirer Z, Golander A.
    Clin Chim Acta; 1984 Mar 27; 138(1):1-8. PubMed ID: 6609026
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Therapeutic monitoring in congenital adrenal hyperplasia using C.I.S. 17-alpha-hydroxyprogesterone radioimmunoassay kit (author's transl)].
    Nakajima F, Machida Y, Amano T, Oya N, Sawada J.
    Horumon To Rinsho; 1980 Mar 27; 28(5):601-5. PubMed ID: 7389169
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Radioimmunoassay for 21-deoxycortisol: clinical applications.
    Gueux B, Fiet J, Pham-Huu-Trung MT, Villette JM, Gourmelen M, Galons H, Brerault JL, Vexiau P, Julien R.
    Acta Endocrinol (Copenh); 1985 Apr 27; 108(4):537-44. PubMed ID: 2986404
    [Abstract] [Full Text] [Related]

  • 11. Serum 21-deoxycortisol and 17-hydroxypregnenolone in parents of patients with congenital adrenal hyperplasia.
    Cassorla F, Tenore A, Parks JS, Marino J, Bongiovanni AM.
    J Endocrinol Invest; 1980 Apr 27; 3(2):137-42. PubMed ID: 6248589
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The inhibition by etomidate of the 11 beta-hydroxylation of cortisol.
    Fry DE, Griffiths H.
    Clin Endocrinol (Oxf); 1984 May 27; 20(5):625-9. PubMed ID: 6744636
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. 21-Deoxycortisol (21-DF) and 17-hydroxyprogesterone (17-OHP) responses to adrenalcorticotropic hormone in males with idiopathic oligozoospermia.
    Milewicz A, Medras M.
    Andrologia; 1987 May 27; 19(3):393-7. PubMed ID: 2820268
    [Abstract] [Full Text] [Related]

  • 20. [21-deoxycortisol. A new marker of virilizing adrenal hyperplasia caused by 21-hydroxylase deficiency].
    Fiet J, Gueux B, Raux-Demay MC, Kuttenn F, Vexiau P, Gourmelen M, Couillin P, Mornet E, Villette JM, Brerault JL.
    Presse Med; 1989 Dec 02; 18(40):1965-9. PubMed ID: 2531882
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.